Fluicell presents T1D implant technology research at Breakthrough T1D Clinical & Research Congress
Fluicell highlighted progress in its type 1 diabetes cell-therapy implant program during the Breakthrough T1D Clinical & Research Congress in Philadelphia on Oct. 9-11. Early-stage work was presented as a scientific poster, not as clinical trial results. Management described the meeting as productive for discussions wi